Ethereum gains 1.80% today returning above $3,500 after the Securities and Exchange Commission (SEC) announced that it is ending its investigation into Ethereum.
The Securities and Exchange Commission (SEC) has concluded its investigation into Ethereum, the second-largest cryptocurrency, determining that it will not bring charges alleging that sales of ETH constitute securities transactions. Consensys, a prominent blockchain firm, received confirmation of this decision following their letter to the SEC, which requested clarification based on the recent approval of ETH ETFs, signaling Ethereum's status as a commodity. This development is seen as a significant win for Ethereum developers and industry participants.
Despite this positive outcome, Consensys remains engaged in a lawsuit against the SEC to further seek clarity on the regulatory status of its MetaMask Swaps and Staking services, arguing that these do not violate securities laws. The company's legal actions were initially prompted by a Wells Notice from the SEC, indicating potential enforcement against MetaMask. The conclusion of the SEC's investigation into Ethereum brings relief to blockchain companies, ensuring they will not face charges for unregistered securities offerings related to Ethereum, yet the broader regulatory uncertainty for the crypto industry persists.
Ethereum (D1)
The price of the second largest cryptocurrency is rebounding after the recent panic sell-off. However, the price still remains low. Interestingly, today we are seeing a rebound mainly on Ethereum and Altcoins, as the Bitcoin price gains just 0.20% above USD 65,000.
Source: xStation 5
Morning Wrap: Ceasefire Fuels Wall Street Gains, but Political Uncertainty Remains
Bitcoin surges almost 4% to the highest level since the beginning of February 2026
Daily Summary: As a ceasefire drifts away, markets lose ground
Chart of the day ๐Bitcoin rebounds above $76k trying to reverse the trend (21.04.2026)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
